Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Darleukin/fibromun

Generic Name: Darleukin/fibromun

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients

Phase 2

Recruiting

Posted: 2024/02/29

Sponsor:

Philogen S.p.A.

ID:NCT06284590

L19IL2/L19TNF in Skin Cancer Patients

Phase 2

Recruiting

Posted: 2022/04/15

Sponsor:

Philogen S.p.A.

ID:NCT05329792

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients

Phase 3

Recruiting

Posted: 2018/06/26

Sponsor:

Philogen S.p.A.

ID:NCT03567889

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

Sun Pharma to Acquire Checkpoint Therapeutics in $355 Million Deal for Novel Skin Cancer Treatment

3 months ago

Sun Pharmaceutical Industries will acquire Checkpoint Therapeutics for $355 million upfront, with stockholders receiving $4.10 per share plus a contingent value right worth up to $0.70 per share based on European approval milestones.

Oncolytic Virus and Toripalimab Combination Shows Promise in Acral Melanoma

6 months ago

A phase Ib trial of neoadjuvant oncolytic virus OrienX010 combined with toripalimab in resectable acral melanoma (AM) demonstrated a 77.8% pathological response rate.

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy